A detailed history of Mc Ilrath & Eck, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 2,613 shares of JNJ stock, worth $423,462. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,613
Previous 2,592 0.81%
Holding current value
$423,462
Previous $410,000 7.07%
% of portfolio
0.08%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $3,031 - $3,313
21 Added 0.81%
2,613 $381,000
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $9,934 - $10,415
64 Added 2.53%
2,592 $410,000
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $1,456 - $1,588
10 Added 0.4%
2,528 $396,000
Q3 2023

Nov 15, 2023

SELL
$155.75 - $174.48 $4,205 - $4,710
-27 Reduced 1.06%
2,518 $392,000
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $2,006 - $2,159
-13 Reduced 0.51%
2,545 $421,000
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $21,147 - $25,236
-140 Reduced 5.19%
2,558 $396,000
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $4,165 - $4,674
26 Added 0.97%
2,698 $476,000
Q3 2022

Oct 18, 2022

BUY
$161.33 - $179.52 $2,419 - $2,692
15 Added 0.56%
2,672 $436,000
Q2 2022

Jul 29, 2022

BUY
$168.19 - $186.01 $37,674 - $41,666
224 Added 9.21%
2,657 $472,000
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $16,840 - $18,685
-108 Reduced 4.25%
2,433 $416,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $178,457 - $198,314
-1,105 Reduced 30.31%
2,541 $410,000
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $318 - $342
2 Added 0.05%
3,646 $601,000
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $62,605 - $69,726
409 Added 12.64%
3,644 $599,000
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $57,174 - $65,627
417 Added 14.8%
3,235 $509,000
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $40,710 - $44,610
290 Added 11.47%
2,818 $420,000
Q2 2020

Aug 04, 2020

BUY
$128.81 - $155.51 $17,131 - $20,682
133 Added 5.55%
2,528 $356,000
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $24,450 - $33,877
-220 Reduced 8.41%
2,395 $314,000
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $37,995 - $43,639
-298 Reduced 10.23%
2,615 $382,000
Q3 2019

Nov 05, 2019

SELL
$126.95 - $142.14 $36,180 - $40,509
-285 Reduced 8.91%
2,913 $377,000
Q1 2019

May 07, 2019

BUY
$125.72 - $139.79 $25,144 - $27,958
200 Added 6.67%
3,198 $447,000
Q4 2018

May 07, 2019

BUY
$122.84 - $147.84 $84,145 - $101,270
685 Added 29.62%
2,998 $387,000
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $51,428 - $60,438
-423 Reduced 15.46%
2,313 $320,000
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $87,042 - $96,053
-729 Reduced 21.04%
2,736 $332,000
Q1 2018

May 22, 2018

SELL
$125.1 - $148.14 $23,518 - $27,850
-188 Reduced 5.15%
3,465 $444,000
Q4 2017

Mar 19, 2018

BUY
$131.22 - $143.62 $479,346 - $524,643
3,653
3,653 $510,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mc Ilrath & Eck, LLC Portfolio

Follow Mc Ilrath & Eck, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.